Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.

Abstract:

:Tamoxifen (Tam), besides its action as an anti-estrogen, also inhibits cell proliferation of estrogen receptor (ER)-negative cancer cells by an unknown mechanism. In this study, we used ER-negative lung cancer cells to clarify such ER-independent inhibitory effect of Tam. We found that Tam induced G1 growth arrest in these cells. However, our results indicated that the expression of G1 cyclins (including D1, 2, 3 and E) was not regulated by Tam in these lung cancer cells. Additionally, the protein levels of G1 acting cyclin-dependent kinases (CDKs), CDK2, 4 and 6, was unaltered in Tam-treated lung cancer cells with the exception of CDK2 expression in H322 cells which was attenuated by Tam in a cell line-specific manner. We next examined the effect of Tam on the expression of cyclin-dependent kinase inhibitors (CDKIs) and our results demonstrated that the expression of p21WAF1 and p27KIP1, but not p57KIP2, was strongly activated by Tam in these cells. The amounts of p21WAF1 and p27KIP1 co-immunoprecipitated with cyclin E were obviously increased after Tam treatment and reduced activity of cyclin E-associated kinases and accumulation of hypo-phosphorylated retinoblastoma (Rb) protein were clearly detected in Tam-incubated cells. No consentaneous induction of CDKIs was found when ER-negative lung cancer cells were incubated with cytotoxic drugs, cisplatin and etoposide, this indicates that enhancement of CDKI expression is not a non-specific effect of Tam. We also found that Tam may up-regulate p21WAF1 expression via transcription activation. Considered together, these results suggest that Tam-induced growth inhibition in ER-negative lung cancer cells is associated with induction of p21WAF1 and p27KIP1.

journal_name

Oncogene

journal_title

Oncogene

authors

Lee TH,Chuang LY,Hung WC

doi

10.1038/sj.onc.1202755

subject

Has Abstract

pub_date

1999-07-22 00:00:00

pages

4269-74

issue

29

eissn

0950-9232

issn

1476-5594

journal_volume

18

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers.

    abstract::Selective inhibition of BCL-2 is expected to enhance therapeutic vulnerability in luminal estrogen receptor-positive breast cancers. We show here that the BCL-2 dependency of luminal tumor cells is nevertheless mitigated by breast cancer-associated fibroblasts (bCAFs) in a manner that defines MCL-1 as another critical...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0635-z

    authors: Louault K,Bonneaud TL,Séveno C,Gomez-Bougie P,Nguyen F,Gautier F,Bourgeois N,Loussouarn D,Kerdraon O,Barillé-Nion S,Jézéquel P,Campone M,Amiot M,Juin PP,Souazé F

    更新日期:2019-04-01 00:00:00

  • Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.

    abstract::The microtubule-targeting antineoplastic agent, paclitaxel, is highly efficacious against a wide spectrum of human cancers. However, dose-limiting toxicity and development of drug resistance limit its clinical application. Development of novel strategies that overcome chemoresistance and sensitize cancer cells to pacl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.23

    authors: Sreekanth CN,Bava SV,Sreekumar E,Anto RJ

    更新日期:2011-07-14 00:00:00

  • Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

    abstract::An essential mode of acquired resistance to radiotherapy (RT) appears to be promotion of tumor cell motility and invasiveness in various cancer types, including glioblastoma, a process resembling 'evasive resistance'. Hence, a logical advancement of RT would be to identify suitable complementary treatment strategies, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.137

    authors: Weiler M,Pfenning PN,Thiepold AL,Blaes J,Jestaedt L,Gronych J,Dittmann LM,Berger B,Jugold M,Kosch M,Combs SE,von Deimling A,Weller M,Bendszus M,Platten M,Wick W

    更新日期:2013-02-28 00:00:00

  • HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas.

    abstract::Amplified segments of the long arm of chromosome 12 are frequently observed in human sarcomas. In most cases there are separate amplified regions around the MDM2 and CDK4 genes. Here we show recurrent amplification of a third region encompassing HMGIC, a human architectural transcription factor gene. Reduced amplifica...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201135

    authors: Berner JM,Meza-Zepeda LA,Kools PF,Forus A,Schoenmakers EF,Van de Ven WJ,Fodstad O,Myklebost O

    更新日期:1997-06-19 00:00:00

  • Regulation of phosphoglucomutase 1 phosphorylation and activity by a signaling kinase.

    abstract::We have identified a novel mechanism of cross-talk between cell signaling and metabolic pathways, whereby the signaling kinase p21-activated kinase 1 (Pak1) binds to, phosphorylates and enhances the enzymatic activity of phosphoglucomutase 1 (PGM), an important regulatory enzyme in cellular glucose utilization and ene...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207969

    authors: Gururaj A,Barnes CJ,Vadlamudi RK,Kumar R

    更新日期:2004-10-21 00:00:00

  • Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference.

    abstract::Tumor necrosis factor alpha (TNF alpha) is a proinflammatory cytokine with important roles in regulating inflammatory responses as well as cell cycle proliferation and apoptosis. Although TNFalpha stimulates apoptosis, it also activates the transcription factor NF-kappa B, and studies have shown that inhibition of NF-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206262

    authors: Zhou A,Scoggin S,Gaynor RB,Williams NS

    更新日期:2003-04-03 00:00:00

  • Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells.

    abstract::LNCaP cells are human prostatic cancer cells that have a frame-shift mutation of the tumor suppressor gene PTEN and do not express the insulin receptor substrate-1 (IRS-1), a major substrate of the type 1 insulin-like growth factor receptor (IGF-IR). Ectopic expression of IRS-1 in LNCaP cells increases cell adhesion a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204112

    authors: Reiss K,Wang JY,Romano G,Tu X,Peruzzi F,Baserga R

    更新日期:2001-01-25 00:00:00

  • Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain.

    abstract::Internal tandem duplication (ITD) of the juxtamembrane (JM) domain of FLT3 is the most frequent mutation in human acute myeloid leukemia, and is significantly associated with leukocytosis and a poor prognosis. Previously we reported that FLT3 with ITD (FLT3/ITD) formed a homodimer and was autophosphorylated on tyrosin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205332

    authors: Kiyoi H,Ohno R,Ueda R,Saito H,Naoe T

    更新日期:2002-04-11 00:00:00

  • CBF mediates adenovirus Ela trans-activation by interaction at the C-terminal promoter targeting domain of conserved region 3.

    abstract::Genetic and biochemical evidence suggest that conserved region 3 (CR3) of the adenovirus Ela polypeptide can provide two distinct and separable functions: an N-terminal transcriptional activation region and a C-terminal promoter targeting region. It is thought that the promoter targeting region of Ela CR3 interacts wi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Agoff SN,Wu B

    更新日期:1994-12-01 00:00:00

  • Post-transcriptional inactivation of p53 in immortalized murine embryo fibroblast cells.

    abstract::The steady-state levels of p53 mRNA and protein were barely detectable by Northern and Western blot analysis in spontaneously immortalized (10)3 and (10)7 murine embryo fibroblast (MEF) cells. But when cells were treated with cycloheximide (CHX) or emetine, expression levels were restored to those observed in primary ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204423

    authors: Kim H,You S,Farris J,Foster LK,Foster DN

    更新日期:2001-05-31 00:00:00

  • Drosophila actin-Capping Protein limits JNK activation by the Src proto-oncogene.

    abstract::The Src family kinases c-Src, and its downstream effectors, the Rho family of small GTPases RhoA and Jun N-terminal kinase (JNK) have a significant role in tumorigenesis. In this report, using the Drosophila wing disc epithelium as a model system, we demonstrate that the actin-Capping Protein (CP) αβ heterodimer, whic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.155

    authors: Fernández BG,Jezowska B,Janody F

    更新日期:2014-04-17 00:00:00

  • The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis.

    abstract::Melanoma is a deadly form of skin cancer that accounts for a disproportionally large proportion of cancer-related deaths in younger people. Compared with most other skin cancers, a feature of melanoma is its high metastatic capacity, although the mechanisms that confer this are not well understood. The Hippo pathway i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1362-9

    authors: Zhang X,Yang L,Szeto P,Abali GK,Zhang Y,Kulkarni A,Amarasinghe K,Li J,Vergara IA,Molania R,Papenfuss AT,McLean C,Shackleton M,Harvey KF

    更新日期:2020-07-01 00:00:00

  • Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.

    abstract::We have characterized a chromosomal translocation in a cell line (SU-DUL5) established from a patient with lymphoblastic lymphoma in which the c-myc gene on chromosome 8 was juxtaposed to a t(14;18). Cytogenetic analysis of this cell line showed 14q+, 18q-, and 8p+q+ marker chromosomes in the absence of t(14;18). Geno...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kiem HP,Nourse J,Saltman DL,Blume KG,Cleary ML

    更新日期:1990-12-01 00:00:00

  • Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.

    abstract::Genomic imprinting at 11p15 is suggested to play a role in certain pediatric tumors such as Wilms' tumor, based on the findings of selective maternal loss of this chromosomal region. Although the allele loss at 11p15 is also frequent in a number of cancers of adults including lung, breast, and bladder cancers, possibl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kondo M,Matsuoka S,Uchida K,Osada H,Nagatake M,Takagi K,Harper JW,Takahashi T,Elledge SJ,Takahashi T

    更新日期:1996-03-21 00:00:00

  • Methyltransferase inhibition induces p53-dependent apoptosis and a novel form of cell death.

    abstract::We have analysed the importance of proper substrate methylation by S-adenosylmethionine-dependent methyltransferases for cell survival and cell cycle progression. We show that treatment of cells with the methyltransferase inhibitor adenosine dialdehyde (AdOx) causes cell cycle arrest and death in different cell types....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208855

    authors: Schwerk C,Schulze-Osthoff K

    更新日期:2005-10-27 00:00:00

  • Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.

    abstract::Alterations in expression of c-myb can have profound effects on the growth and differentiation of hematopoietic cells. Thus, it is important to understand the mechanisms by which c-myb is regulated during hematopoietic cell differentiation. Previous studies pertaining to the regulation of c-myb have been carried out w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Boise LH,Gorse KM,Westin EH

    更新日期:1992-09-01 00:00:00

  • Cis/trans-activation of the interleukin-9 receptor gene in an HTLV-I-transformed human lymphocytic cell.

    abstract::The MT-2 cell-line, which had been established through in vitro cell to cell transmission of human T-cell leukemia virus type I (HTLV-I) among human primary lymphocytes, was shown to possess multiple copies of integrated proviruses, including defective proviral genomes. By analysing a genomic clone, we identified the ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kubota S,Siomi H,Hatanaka M,Pomerantz RJ

    更新日期:1996-04-04 00:00:00

  • The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.

    abstract::The BCL6 gene, mapped at the chromosomal band 3q27, encodes a POZ/Zinc finger transcription repressor protein. It is frequently activated in Non-Hodgkin's lymphomas (NHL) by translocations with breakpoints clustering in the 5' major breakpoint region (MBR) as well as by mutations in the same region. The translocations...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202098

    authors: Chen W,Butler M,Rao PH,Chaganti SR,Louie DC,Dalla-Favera R,Chaganti RS

    更新日期:1998-10-01 00:00:00

  • Towards a blueprint of the cell cycle.

    abstract::The understanding of the organisation of cell cycle events is of utmost importance to devise effective therapeutic strategies for cancer. In this article we gather evidences from the literature in support of a system model of the cell cycle, in which a growth-sensitive threshold controls entry into S phase and the seq...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204263

    authors: Alberghina L,Porro D,Cazzador L

    更新日期:2001-03-01 00:00:00

  • Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: favouring role of hypoxia-inducible factor-1 deficiency.

    abstract::Two hepatocarcinoma cell lines, the Hepa-1 wild-type (c1c7) and the beta-subunit mutated (c4) lacking hypoxia-inducible factor-1 (HIF-1) activity, were differentially susceptible to apoptosis by hepatocyte growth factor (HGF). The c4 cells were 40% apoptotic 48 h after HGF treatment. On the contrary, the wild-type c1c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206519

    authors: Matteucci E,Modora S,Simone M,Desiderio MA

    更新日期:2003-06-26 00:00:00

  • Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B.

    abstract::SEMA3B, a member of class 3 semaphorins, is a tumor suppressor. Competition with vascular endothelial growth factor (VEGF)165 explains a portion of the activity, whereas the VEGF-independent mechanism was not elucidated. We employed a microarray and screened for the genes whose expression was increased by SEMA3B in NC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.263

    authors: Koyama N,Zhang J,Huqun,Miyazawa H,Tanaka T,Su X,Hagiwara K

    更新日期:2008-11-20 00:00:00

  • MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells.

    abstract::Over 70% of human breast cancers are estrogen receptor-positive (ER+), most of which express MYB. In these and other cell types, the MYB transcription factor regulates the expression of many genes involved in cell proliferation, differentiation, tumorigenesis, and apoptosis. So far, no clear link has been established ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0789-3

    authors: Yang RM,Nanayakkara D,Kalimutho M,Mitra P,Khanna KK,Dray E,Gonda TJ

    更新日期:2019-06-01 00:00:00

  • The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family.

    abstract::Apoptosis is essential for normal development and maintenance of homeostasis, and disruption of apoptotic pathways is associated with multiple disease states, including cancer. Although initially identified as central regulators of apoptosis at the level of mitochondria, an important role for BCL-2 proteins at the end...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2008.309

    authors: Heath-Engel HM,Chang NC,Shore GC

    更新日期:2008-10-27 00:00:00

  • Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation.

    abstract::Leukemogenesis requires two classes of mutations, one that promotes proliferation and one that blocks differentiation. The erythroleukemia induced by Friend virus is a multistage disease characterized by an early proliferative stage driven by the interaction of the viral glycoprotein, gp55, with Sf-Stk and the EpoR, a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.202

    authors: Hegde S,Ni S,He S,Yoon D,Feng GS,Watowich SS,Paulson RF,Hankey PA

    更新日期:2009-09-24 00:00:00

  • Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.

    abstract::Interleukin-8 (IL-8), a chemokine implicated in the metastasis and angiogenesis of a variety of cancers, has been reported to be overexpressed in prostate cancer. In this study, we ascribe a new role for IL-8 in prostate cancer progression using LNCaP cells. We demonstrate that IL-8 activates the androgen receptor and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207344

    authors: Lee LF,Louie MC,Desai SJ,Yang J,Chen HW,Evans CP,Kung HJ

    更新日期:2004-03-18 00:00:00

  • Transcript map and complete genomic sequence for the 310 kb region of minimal allele loss on chromosome segment 11p15.5 in non-small-cell lung cancer.

    abstract::Molecular, functional, and clinical analyses strongly suggest that chromosome segment 11p15.5 contains a gene involved in lung cancer pathogenesis. The critical region of allele loss is 310 kb in size. We used our contig of P1-phage artificial chromosome (PAC) clones together with newly identified bacterial artificial...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205027

    authors: Zhao B,Bepler G

    更新日期:2001-12-06 00:00:00

  • Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells.

    abstract::Mesenchymal stromal cells (MSCs) are strongly immunosuppressive via producing nitric oxide (NO) and known to migrate into tumor sites to promote tumor growth, but the underlying mechanisms remain largely elusive. Here, we found that interferon alpha (IFNα)-secreting MSCs showed more dramatic inhibition effect on tumor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.128

    authors: Shou P,Chen Q,Jiang J,Xu C,Zhang J,Zheng C,Jiang M,Velletri T,Cao W,Huang Y,Yang Q,Han X,Zhang L,Wei L,Rabson AB,Chin YE,Wang Y,Shi Y

    更新日期:2016-11-17 00:00:00

  • Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.

    abstract::Synemin (SYNM) is a type IV intermediate filament that has recently been shown to interact with the LIM domain protein zyxin, thereby possibly modulating cell adhesion and cell motility. Owing to this multiplicity of potential functions relevant to cancer development, we initiated a study to decipher SYNM expression a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.229

    authors: Noetzel E,Rose M,Sevinc E,Hilgers RD,Hartmann A,Naami A,Knüchel R,Dahl E

    更新日期:2010-08-26 00:00:00

  • Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity.

    abstract::The aspartic protease cathepsin D (cath-D) is a key mediator of induced-apoptosis and its proteolytic activity has been generally involved in this event. During apoptosis, cath-D is translocated to the cytosol. Because cath-D is one of the lysosomal enzymes that requires a more acidic pH to be proteolytically active r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209221

    authors: Beaujouin M,Baghdiguian S,Glondu-Lassis M,Berchem G,Liaudet-Coopman E

    更新日期:2006-03-23 00:00:00

  • Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.

    abstract::We have evaluated the transcriptional activation of a human p21 promoter reporter construct by transfection of BRCA1 expression constructs into tumorigenic and nontumorigenic human breast cell lines. Two cell lines with wildtype p53 (MCF-7 and MCF10A) demonstrated transcriptional activation of the p21 promoter by full...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204025

    authors: Lu M,Arrick BA

    更新日期:2000-12-14 00:00:00